EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues

Jordan M Broekhuis, Dongli Lu, Rajindra P Aryal iD, Yasuyuki Matsumoto iD, Lauren E Pepi iD, Natalia Chaves iD, Jorge L Gomez-Mayorga iD, Benjamin C James, Richard D Cummings

Biomolecules · 2024

DOI: 10.3390/biom14121482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Jordan M Broekhuis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Polysaccharides, Thyroid Neoplasms, Glycoproteins, Galactose. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant protein glycosylation is a hallmark alteration of cancer and is highly associated with cancer progression. Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, but the N-glycosylation of its glycoproteins has not been well characterized. In this work, we analyzed multiple freshly prepared PTC specimens along with paired normal tissue obtained from thyroidectomies. Glycomic analyses focused on Asn-linked (N)-glycans and employed mass spectrometry (MS), along with Western blot approaches of total solubilized materials that were examined for binding by specific lectins and a monoclonal antibody (mAb) O6, specific for 3-O-sulfated galactose residues. We observed major differences in PTC versus paired normal specimens, as PTC specimens exhibited higher levels of N-glycan branching and bisection with N-acetylglucosamine residues, consistent with RNAseq data. We also found that 3-O-sulfated galactose was present in N-glycans of multiple glycoproteins from both PTC and control specimens, as recognized by the O6 mAb and as confirmed by MS analyses. These results provide new insights into the N-glycans present in glycoproteins of thyroid cancer and context for further studies of these altered glycans as biomarkers and targets for therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesThyroid NeoplasmsGlycoproteinsGalactoseHumansGlycosylationThyroid Cancer, PapillaryGlycomics

Stichwörter der Autor:innen

GlcNAc bisectionRNAseqglycosylationlectin histochemistrymass spectrometrypapillary thyroid cancersialylationsulfationsulfoglycomicsthyroid carcinomawestern blotting

Substanzen

PolysaccharidesGlycoproteinsGalactose

Autor:innen und Institutionen

  • Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

ORCID-Profile: Rajindra P Aryal, Yasuyuki Matsumoto, Lauren E Pepi, Natalia Chaves, Jorge L Gomez-Mayorga

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • NIH
  • Massachusetts Life Science Center

Zitieren

APA

Broekhuis, J. M., Lu, D., Aryal, R. P., Matsumoto, Y., Pepi, L. E., Chaves, N., Gomez-Mayorga, J. L., James, B. C., & Cummings, R. D. (2024). Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues. Biomolecules. https://doi.org/10.3390/biom14121482

Vancouver

Broekhuis JM, Lu D, Aryal RP, Matsumoto Y, Pepi LE, Chaves N, et al. Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues. Biomolecules. 2024. doi:10.3390/biom14121482

BibTeX
@article{Broekhuis2024,
  author = {Broekhuis, Jordan M and Lu, Dongli and Aryal, Rajindra P and Matsumoto, Yasuyuki and Pepi, Lauren E and Chaves, Natalia and Gomez-Mayorga, Jorge L and James, Benjamin C and Cummings, Richard D},
  title = {Thyroid Carcinoma Glycoproteins Express Altered N-Glycans with 3-O-Sulfated Galactose Residues},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14121482}
}
Kostenlos starten →